MiR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2

Biochemical and Biophysical Research Communications

Volumn 468, Issue 4, 2015, Pages 739-745

  Pang, Hengyuan ^a   Zheng, Yongri ^a   Zhao, Yan ^a   Xiu, Xiaoqing ^a   Wang, Jianjiao ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition (EMT); Glioma; Invasion; Migration; miR 590 3p; ZEB1 2

Indexed keywords

MICRORNA; MICRORNA 590 3P; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTION FACTOR ZEB2; TUMOR MARKER; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MIRN590 MICRORNA, HUMAN; REPRESSOR PROTEIN; ZEB1 PROTEIN, HUMAN; ZEB2 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; A172 CELL LINE; ARTICLE; BIOINFORMATICS; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; U87MG CELL LINE; WESTERN BLOTTING; CELL MOTION; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GLIOBLASTOMA; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84949623268     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.11.025     Document Type: Article

References (28)

1. O.M. Grauer, P. Wesseling, and G.J. Adema Immunotherapy of diffuse gliomas: biological background, current status and future developments Brain Pathol. 19 2009 674 693
2. J.A. Schwartzbaum, J.L. Fisher, K.D. Aldape, and M. Wrensch Epidemiology and molecular pathology of glioma Nat. Clin. Pract. Neurol. 2 2006 494 503 quiz 491 p following 516
3. R. Stupp, W.P. Mason, M.J. van den Bent, M. Weller, B. Fisher, M.J. Taphoorn, K. Belanger, A.A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R.C. Janzer, S.K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J.G. Cairncross, E. Eisenhauer, R.O. Mirimanoff, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, and National Cancer Institute of Canada Clinical Trials Group Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 2005 987 996
4. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
5. J. Yin, G. Park, J.E. Lee, E.Y. Choi, J.Y. Park, T.H. Kim, N. Park, X. Jin, J.E. Jung, D. Shin, J.H. Hong, H. Kim, H. Yoo, S.H. Lee, Y.J. Kim, J.B. Park, and J.H. Kim DEAD-box RNA helicase DDX23 modulates glioma malignancy via elevating miR-21 biogenesis Brain 138 2015 2553 2570
6. X. Li, Y. Liu, K.J. Granberg, Q. Wang, L.M. Moore, P. Ji, J. Gumin, E.P. Sulman, G.A. Calin, H. Haapasalo, M. Nykter, I. Shmulevich, G.N. Fuller, F.F. Lang, and W. Zhang Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma Oncogene 34 2015 1619 1628
7. Y. Zhang, J. Kim, A.C. Mueller, B. Dey, Y. Yang, D.H. Lee, J. Hachmann, S. Finderle, D.M. Park, J. Christensen, D. Schiff, B. Purow, A. Dutta, and R. Abounader Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma Cell Death Differ. 21 2014 720 734
8. S. Dai, X. Wang, X. Li, and Y. Cao MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme Biochem. Biophys. Res. Commun. 467 2015 204 210
9. A. Gheldof, P. Hulpiau, F. van Roy, B. De Craene, and G. Berx Evolutionary functional analysis and molecular regulation of the ZEB transcription factors Cell. Mol. Life Sci. 69 2012 2527 2541
10. S. Brabletz, and T. Brabletz The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep. 11 2010 670 677
11. H.L. Chua, P. Bhat-Nakshatri, S.E. Clare, A. Morimiya, S. Badve, and H. Nakshatri NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 Oncogene 26 2007 711 724
12. M. Hashiguchi, S. Ueno, M. Sakoda, S. Iino, K. Hiwatashi, K. Minami, K. Ando, Y. Mataki, K. Maemura, H. Shinchi, S. Ishigami, and S. Natsugoe Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC) BMC Cancer 13 2013 572
13. J. Kurashige, H. Kamohara, M. Watanabe, Y. Hiyoshi, M. Iwatsuki, Y. Tanaka, K. Kinoshita, S. Saito, Y. Baba, and H. Baba MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma Ann. Surg. Oncol. 19 suppl. 3 2012 S656 S664
14. W.L. Tam, and R.A. Weinberg The epigenetics of epithelial-mesenchymal plasticity in cancer Nat. Med. 19 2013 1438 1449
15. M. Du, D. Shi, L. Yuan, P. Li, H. Chu, C. Qin, C. Yin, Z. Zhang, and M. Wang Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer Sci. Rep. 5 2015 10437
16. E. Zoni, G. van der Horst, A.F. van de Merbel, L. Chen, J.K. Rane, R.C. Pelger, A.T. Collins, T. Visakorpi, B.E. Snaar-Jagalska, N.J. Maitland, and G. van der Pluijm miR-25 modulates invasiveness and dissemination of human prostate cancer cells via regulation of alphav- and alpha6-integrin expression Cancer Res. 75 2015 2326 2336
17. T. Que, Y. Song, Z. Liu, S. Zheng, H. Long, Z. Li, Y. Liu, G. Wang, Y. Liu, J. Zhou, X. Zhang, W. Fang, and S. Qi Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1 Oncogene 34 2015 4952 4963
18. G. Qiu, Y. Lin, H. Zhang, and D. Wu miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2 Biochem. Biophys. Res. Commun. 463 2015 315 321
19. H. Guan, W. Liang, Z. Xie, H. Li, J. Liu, L. Liu, L. Xiu, and Y. Li Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2 Endocrine 48 2015 566 574
20. W. Liu, J. An, K. Li, and H. Hou MiR-429 regulates gastric cancer cell invasiveness through ZEB proteins Tumour Biol. 2015 10.1007/s13277-015-4094-7
21. F. Guo, D. Cogdell, L. Hu, D. Yang, A.K. Sood, F. Xue, and W. Zhang MiR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma Oncol. Rep. 31 2014 2021 2028
22. N. Cong, P. Du, A. Zhang, F. Shen, J. Su, P. Pu, T. Wang, J. Zjang, C. Kang, and Q. Zhang Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma Oncol. Rep. 29 2013 1579 1587
23. S. Yue, L. Wang, H. Zhang, Y. Min, Y. Lou, H. Sun, Y. Jiang, W. Zhang, A. Liang, Y. Guo, P. Chen, G. Lv, L. Wang, Q. Zong, and Y. Li miR-139-5p suppresses cancer cell migration and invasion through targeting ZEB1 and ZEB2 in GBM Tumour Biol. 36 2015 6741 6749
24. H. Yang, W. Zheng, W. Zhao, C. Guan, and J. An Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma Nan Fang Yi Ke Da Xue Xue Bao 33 2013 804 811
25. D. Yao, C. Dai, and S. Peng Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation Mol. Cancer Res. 9 2011 1608 1620
26. I. de Krijger, L.J. Mekenkamp, C.J. Punt, and I.D. Nagtegaal MicroRNAs in colorectal cancer metastasis J. Pathol. 224 2011 438 447
27. S.M. Park, A.B. Gaur, E. Lengyel, and M.E. Peter The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2 Genes Dev. 22 2008 894 907
28. T. Kim, A. Veronese, F. Pichiorri, T.J. Lee, Y.J. Jeon, S. Volinia, P. Pineau, A. Marchio, J. Palatini, S.S. Suh, H. Alder, C.G. Liu, A. Dejean, and C.M. Croce p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2 J. Exp. Med. 208 2011 875 883